What is Shandong Weigao Group Medical Polymer Co Ltd ADR?
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally.
SHWGY · Verdict
Moderate reward · low risk
SHWGY stands out on balance sheet and volatility, but watch the growth signal.
Based on 88% data coverage
SHWGY · Verdict
Interest covered 11.2×
Top decile vs peers
P/E 9.4×
16% free-cash-flow margin
Rev -0.2% CAGR · earnings -3.2%
Model-based scoring. For information only — not financial advice.
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.69B, and a P/E ratio of 9.4x.
The scoring profile indicates limited reward potential at this time, with valuation and profitability offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.